[1]
K. El-Reshaid and S. Al-Bader, “The limited role and risky profile of Rituximab in nephritis associated with Henoch-Schönlein purpura”, J. Drug Delivery Ther., vol. 9, no. 6-s, pp. 12–15, Dec. 2019, doi: 10.22270/jddt.v9i6-s.3744.